Atomwise & Atropos (Joint Venture) Overview

  • Status
  • Private

  • Latest Deal Type
  • Joint Venture

  • Financing Rounds
  • 1

Atomwise & Atropos (Joint Venture) General Information

Description

Provider of drug discovery services. The company engages in drug discovery using artificial intelligence and cellular senescence to treat cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 717 Market Street
  • Suite 800
  • San Francisco, CA 94103
  • United States
Primary Industry
Drug Discovery
Vertical(s)
Artificial Intelligence & Machine Learning, Life Sciences, Oncology
Corporate Office
  • 717 Market Street
  • Suite 800
  • San Francisco, CA 94103
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Atomwise & Atropos (Joint Venture) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Atomwise & Atropos (Joint Venture)‘s full profile, request access.

Request a free trial

Atomwise & Atropos (Joint Venture) Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Atomwise & Atropos (Joint Venture)‘s full profile, request access.

Request a free trial

Atomwise & Atropos (Joint Venture) FAQs

  • Where is Atomwise & Atropos (Joint Venture) headquartered?

    Atomwise & Atropos (Joint Venture) is headquartered in San Francisco, CA.

  • What industry is Atomwise & Atropos (Joint Venture) in?

    Atomwise & Atropos (Joint Venture)’s primary industry is Drug Discovery.

  • Is Atomwise & Atropos (Joint Venture) a private or public company?

    Atomwise & Atropos (Joint Venture) is a Private company.

  • What is Atomwise & Atropos (Joint Venture)’s current revenue?

    The current revenue for Atomwise & Atropos (Joint Venture) is .

  • Who are Atomwise & Atropos (Joint Venture)’s investors?

    Atropos Therapeutics and Numerion Labs have invested in Atomwise & Atropos (Joint Venture).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process